Alembic launches generic Temovate

Press enter to search
Close search
Open Menu

Alembic launches generic Temovate

By Sandra Levy - 01/07/2020

Alembic is debuting clobetasol propionate topical solution in a dosage strength of 0.05%.

The product is the generic of Fougera’s Temovate topical solution.

It is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.

Alembic’s clobetasol propionate topical solution is available in 25-ml and 50-ml bottles.

Related Topics